Revenue YoY
+9.50%
Operating Income YoY
+72.17%
Net Income YoY
-13.30%
Net Margin Δ
-151 bps
Net income bridge for AbbVie (ABBV) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: −$556.00M-13.30%
Profit bridge breakdown for AbbVie (ABBV) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | $4.20B | — |
| Revenue | $5.45B | +980.6% |
| Cost of Revenue | −$1.61B | -289.2% |
| Operating Expenses | $3.42B | +616.0% |
| Other Income / Expense | −$4.92B | -884.2% |
| Income Tax | −$2.92B | -524.3% |
| Other Items | $6.00M | +1.1% |
| Net Income | $3.64B | — |
- Prior Net Income$4.20B
- Revenue$5.45B
- Cost of Revenue−$1.61B
- Operating Expenses$3.42B
- Other Income / Expense−$4.92B
- Income Tax−$2.92B
- Other Items$6.00M
- Net Income$3.64B
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement